Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News QIAGEN files lawsuit against bioMérieux to defend QuantiFERON patents and innovation in TB diagnostics QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has initiated legal proceedings against bioMérieux S.A. (EPA: BIM) in… byPallavi MadhirajuMarch 3, 2025